A16AB06 • sacrosidas • Alimentary tract and metabolism | Other alimentary tract and metabolism products | Enzymes
Sacrosidase is a digestive enzyme used in the treatment of sucrase-isomaltase deficiency, a rare genetic condition that affects the digestion of complex sugars such as sucrose and starch. This enzyme replaces the activity of sucrase-isomaltase, facilitating the breakdown of sugars into simpler components that can be absorbed by the intestine.
Sacrosidase is administered orally, usually in liquid form, and is indicated for patients diagnosed with this enzymatic deficiency. It is used to reduce gastrointestinal symptoms such as diarrhea, bloating, and abdominal pain associated with the consumption of foods containing complex sugars.
Common side effects include abdominal discomfort, nausea, and reactions at the site of administration. In rare cases, severe allergic reactions such as anaphylaxis may occur. It is important for patients to follow an appropriate diet and use sacrosidase as directed by their healthcare provider.
Sacrosidase is an effective therapeutic option for patients with sucrase-isomaltase deficiency, helping to improve digestion and reduce gastrointestinal symptoms.
Substance: sacrosidas
Date of last drug list: 01-04-2025
Commercial code: W70157001
Concentration: 8500UI / ml
Pharmaceutical form: oral solution
Quantity: 2
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: IMMEDICA PHARMA AB - SUEDIA
Holder: CN UNIFARM S.A. - ROMANIA
Number: 882/2024/01